[RCUS] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[RCUS] Arcus Biosciences, Inc.
Announcement Date
28-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -10.85%
YoY- -123.98%
Quarter Report
RCUS's Result
RCUS's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 32,000 29,000 25,000 345 33,581 26,759 18,005 46.67%
PBT -69,000 -74,000 -78,000 -67,000 -64,919 -66,632 -66,989 1.98%
Tax 2,000 1,000 2,000 -4 -4,478 -2,350 1,004 58.25%
NP -71,000 -75,000 -80,000 -66,996 -60,441 -64,282 -67,993 2.92%
Tax Rate - - - - - - - -
Total Cost 103,000 104,000 105,000 67,341 94,022 91,041 85,998 12.76%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -221.88 -258.62 -320.00 -19,419.13 -179.99 -240.23 -377.63 -29.82%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.95 -1.02 -1.10 -0.92 -0.84 -0.90 -0.96 -0.69%
EPS Diluted -0.95 -1.02 -1.10 -0.92 -0.84 -0.90 -0.96 -0.69%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.